Brief: Lansen Pharmaceutical Holdings Appoints Chen Li As Executive Managing Director & CEO
09/02/2018 04:12
Feb 9 (Reuters) - Lansen Pharmaceutical Holdings Ltd
0503.HK :
* CHEN LI TO BE APPOINTED AS EXECUTIVE MANAGING DIRECTOR &
CEO
Source text for Eikon: urn:newsml:reuters.com:*:nHKS3mvRbd
Further company coverage: 0503.HK
(bangalore.newsroom@thomsonreuters.com)
Recent news on Lansen Pharmaceutical Holdings
See all newsBrief: Lansen Pharmaceutical Says Stock Exchange Approved Withdrawal Of Listing Of Shares From 9 AM, 19 Dec
Brief: Lansen Pharmaceutical Updates Withdrawal Of Listing Of Shares On Stock Exchange
Brief: Lansen Pharmaceutical Says Trading In Shares Will Be Halted
Brief: Lansen Pharmaceutical Posts FY Revenue Of $65.6 Mln VS $54.2 Mln
Brief: Lansen Pharmaceutical Sees Net Profit Attributable Of Approximately $8.1 Million For Year